Our findings indicate that neuroinflammation also interplays with Aβ and tau synergistic effects, which seems to be a key factor in AD’s pathophysiology (Busche and Hyman, 2020; Sanchez-Rodriguez et al., 2024). This evidence concerns the gene MAPT and Alzheimer disease.